Illuccix
Ended Awarded Last action
- Contract number
- 36C24423N0069
- Awardee
-
Nuclear Diagnostic Products Of Philadelphia, Inc. UEI QJKJD5FKTNP3 Part of Nuclear Diagnostic Products, Inc.
- Awarding agency
-
Veterans Integrated Service Network 4
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $367,800
Award facts
- Contract value 4% obligated
-
- $367,800.00 Current, with exercised options
- $9,345,300.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$629,700 | |
| Original award | $997,500 |
About this award
Nuclear Diagnostic Products of Philadelphia, Inc., doing business as Cherry Hill Pharmacy, has been awarded delivery order contracts totaling over $9.3 million by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 (VA-VHA VISN 4) to supply the radiopharmaceutical product ILLUCCIX Gallium 68 PSMA-11. The contracts have no set-aside designation. Cherry Hill Pharmacy holds a single-award Indefinite Delivery Contract from VA-VHA VISN 4 with a potential value of $9.345 million over five years to provide ILLUCCIX. Two delivery orders have been issued against this contract so far, including the initial $5 million delivery order awarded November 4, 2022 for fulfillment through November 3, 2027 out of Cherry Hill Pharmacy's Philadelphia, Pennsylvania facility. A subsequent $1.176 million delivery order was awarded November 4, 2023 for the same product and period of performance. Both utilize firm fixed pricing. ILLUCCIX supports nuclear medicine imaging procedures for veterans within the VA-VHA VISN 4 region. Nuclear Diagnostic Products, Inc. is the prime contractor's parent company and provides additional radiopharmaceuticals to VA medical centers.
Quick answers
Who was awarded contract 36C24423N0069?
36C24423N0069 was awarded to Nuclear Diagnostic Products Of Philadelphia, Inc. by Veterans Integrated Service Network 4 (Veterans Health Administration) on November 4, 2022.
How much is contract 36C24423N0069 worth?
The government has obligated $367,800 on 36C24423N0069. Its potential value, with all options, is $9,345,300.
Is contract 36C24423N0069 an order under another contract?
Yes. 36C24423N0069 is a delivery order under 36C24423D0013, an indefinite delivery contract.
Was contract 36C24423N0069 competed?
The extent of competition for 36C24423N0069 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award